Strengthening immunisation supply chain systems through the GAVI Alliance Immunisation Supply Chain Strategy by Kaleb Brownlow, Daniel Thornton

Get full text

Perceptions of the usefulness of external support to immunization coverage in Guinea-Bissau: a Delphi analysis of the GAVI-Alliance cash-based support by Paulo Ferrinho, Mohamed Dramé, Sidu Biai, Orlando Lopes, Fernando de Sousa Jr, Wim Van Lerberghe

Subjects: Get full text

Title not available by Paulo Ferrinho, Mohamed Dramé, Sidu Biai, Orlando Lopes, Fernando de Sousa Jr, Wim Van Lerberghe

Subjects: Get full text

Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. by Stacey Perlman, Richard G Wamai, Paul A Bain, Thomas Welty, Edith Welty, Javier Gordon Ogembo

“…We further identified countries that fulfill the two GAVI Alliance eligibility criteria to support nationwide HPV vaccination.…”
Get full text

Advance market commitment for pneumococcal vaccines: putting theory into practice by Tania Cernuschi, Eliane Furrer, Nina Schwalbe, Andrew Jones, Ernst R Berndt, Susan McAdams

Get full text

Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan. by Ulla K Griffiths, Andrew Clark, Veronika Shimanovich, Irina Glinskaya, Dilorom Tursunova, Lucia Kim, Liudmila Mosina, Rana Hajjeh, Karen Edmond

“…BACKGROUND: Hib vaccine has gradually been introduced into more and more countries during the past two decades, partly due to GAVI Alliance support to low-income countries. However, since Hib disease burden is difficult to establish in settings with limited diagnostic capacities and since the vaccine continues to be relatively expensive, some Governments remain doubtful about its value leading to concerns about financial sustainability. …”
Get full text

Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline. by E A S Nelson, David E Bloom, Richard T Mahoney

“…DAC country contributions to the GAVI Alliance for 2009 were assessed as a measure of multilateral donor support for vaccines and immunization programs. …”
Get full text

HPV Vaccine to GAVI for US$5 per Dose! by Marc Steben MD

“… The Global Alliance for Vaccines and Immunisation, GAVI Alliance for short, recently announced a vaccine price reduction from Merck & Co., Inc. to provide HPV vaccine at US$5 per dose. …”
Get full text

Reflections on the Addis Ababa Immunization Conference of 2016 by Robert Davis

“…In 1985, there was no Gates Foundation, there was no Global Vaccine Alliance (GAVI) Alliance, and there was no global commitment to polio eradication.…”
Get full text

Australia's contribution to global immunisation by Tilman A. Ruff, Kate Taylor, Terry Nolan

“…Given the importance of immunisation to health gains, Australia is well placed to expand its investment in immunisation within its development portfolio. The GAVI Alliance is the best‐established global mechanism to do this. …”
Get full text

Three decades of USAID investments in immunization through the child survival revolution by Richard Murray Trostle, Angela K Shen

“…Investments such as polio eradication and vaccine purchase through the GAVI Alliance (formerly the Global Alliance for Vaccines and Immunization) became funding priorities for the Agency. …”
Get full text

Accelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysis. by Jessica C Shearer, Meghan L Stack, Marcie R Richmond, Allyson P Bear, Rana A Hajjeh, David M Bishai

“…Using the case of Haemophilus influenzae type b (Hib) vaccine, this paper endeavors to explain these delays through the analysis of country-level economic, epidemiological, programmatic and policy-related factors, as well as the role of the Global Alliance for Vaccines and Immunisation (GAVI Alliance).Data for 147 countries from 1990 to 2007 were analyzed in accelerated failure time models to identify factors that are associated with the time to decision to adopt Hib vaccine. …”
Get full text

Infant and under-five mortality in Afghanistan: current estimates and limitations by Kavitha Viswanathan, Stan Becker, Peter M Hansen, Dhirendra Kumar, Binay Kumar, Haseebullah Niayesh, David H Peters, Gilbert Burnham

Get full text

Trends in the quality of health care for children aged less than 5 years in Afghanistan, 2004-2006 by Anbrasi Edward, Vikas Dwivedi, Lais Mustafa, Peter M Hansen, David H Peters, Gilbert Burnham

Get full text

Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines. by Aharona Glatman-Freedman, Mary-Louise Cohen, Katherine A Nichols, Robert F Porges, Ivy Rayos Saludes, Kevin Steffens, Victor G Rodwin, David W Britt

“…BACKGROUND: A major effort to introduce new vaccines into poor nations of the world was initiated in recent years with the help of the GAVI alliance. The first vaccines introduced have been the Haemophilus influenzae type B (Hib) and the hepatitis B (Hep B) vaccines. …”
Get full text

Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya. by Moses Muia Masika, Javier Gordon Ogembo, Sophie Vusha Chabeda, Richard G Wamai, Nelly Mugo

“…The aim of this study is to assess primary school teachers' knowledge and acceptability of HPV vaccine and to explore facilitators and barriers of an ongoing Gavi Alliance-supported vaccination program in Kitui County, Kenya.This was a cross-sectional, mixed methods study in Central Division of Kitui County where the Ministry of Health is offering the quadrivalent HPV vaccine to grade four girls. …”
Get full text

Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination by Cover Jane K, Nghi Nguyen, LaMontagne D, Huyen Dang Thi, Hien Nguyen, Nga Le

“…<p>Abstract</p> <p>Background</p> <p>The GAVI Alliance’s decision in late 2011 to invite developing countries to apply for funding for human papillomavirus (HPV) vaccine introduction underscores the importance of understanding levels of HPV vaccine acceptance in developing country settings. …”
Get full text

Rotavirus immunization: Global coverage and local barriers for implementation by Vecchio, A, Liguoro, I, Dias, J, Berkley, J, Boey, C, Cohen, M, Cruchet, S, Salazar-Lindo, E, Podder, S, Sandhu, B, Sherman, P, Shimizu, T, Guarino, A

“…The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. …”

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme by Agnes Binagwaho, Claire M Wagner, Maurice Gatera, Corine Karema, Cameron T Nutt, Fidele Ngabo

“…High coverage rates were achieved due to a delivery strategy that built on Rwanda's strong vaccination system and human resources framework. Following the GAVI Alliance's decision to begin financing HPV vaccination, Rwanda's example should motivate other countries to explore universal HPV vaccine coverage, although implementation must be tailored to the local context.…”
Get full text

Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a "3+0" schedule... by Sylvia Becker-Dreps, Bryan Blette, Rafaela Briceño, Jorge Alemán, Michael G Hudgens, Gilberto Moreno, Ana Ordoñez, Julio Rocha, David J Weber, Erick Amaya

“…Nicaragua was the first country eligible for GAVI Alliance funding to introduce the 13-valent pneumococcal conjugate vaccine (PCV13) in 2010, provided to infants at 2, 4, and 6 months of age. …”
Get full text